AzTrials
AzTrials

MalariaREACTNCT01350752

Research on the Economics of Artemisinin Combination Therapy (ACTs) for the Treatment of Malaria

A study testing RDTs & Provider Training on Malaria Diagnosis and Treatment, Extended provider training (Cameroon only) and School based malaria education (Nigeria only) in people with Malaria, run by London School of Hygiene and Tropical Medicine at 3 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of the REACT project is to evaluate the effectiveness and cost-effectiveness implications of interventions designed to improve health worker practice in providing treatment for uncomplicated malaria to febrile patients attending health facilities in Cameroon and Nigeria. Read more about this study

Who is it for?
Ages 6 months and older
Conditions the study is for
Malaria
What is being tested?
RDTs & Provider Training on Malaria Diagnosis and Treatment, Extended provider training (Cameroon only) and School based malaria education (Nigeria only)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
6,513 participants
Where
3 sitesin 2 countries
Study dates
May 2011to Jan 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • the patient (or their caregiver) reports that the patient is suffering from a fever or has a history of fever in this illness episode
  • the patient is present at the health facility

Who cannot join

  • the patient is pregnant
  • the patient is <6 months old
  • the patient has signs or symptoms of severe malaria

Trial locations and contacts

3 sites in 2 countries.

3 sites in 2 countries

Cameroon2 sites
  • Various health facilities

    Bamenda, North-West Region

  • Various health facilities

    Yaoundé, Central Region

Other trials in Cameroon

Nigeria1 site
  • Various health facilities

    Enugu, Enugu State

Other trials in Nigeria

About this study

Official title: A Cost-effectiveness Analysis of Alternative Strategies for the Deployment of ACTs at the Community Level in Cameroon and Nigeria

The objective of the REACT project is to evaluate the effectiveness and cost-effectiveness implications of interventions designed to improve health worker practice in providing treatment for uncomplicated malaria to febrile patients attending health facilities in Cameroon and Nigeria.

Read the detailed description

NIGERIA

Two interventions will be evaluated: (i) provider intervention including introducing RDTs with detailed instructions, one-off training, job aides and on-the-site supportive supervisory visits and (ii) combined provider intervention [as under (i)]and community-based intervention (using primary and secondary schools as focal points)including school malaria events with drama, peer-health education, distribution of health education materials. Types of facilities include: public primary health facilities, private pharmacies and private Patent Medicine Dealers (PMDs)in Enugu State. The two sites in Enugu State are: Enugu urban (comprising of Enugu East, Enugu South and Enugu North Local government areas (LGA) and Udi LGA. The impact of the interventions will be evaluated using a 3-arm stratified, cluster randomized trial with a cluster defined as a geographical community and the two study sites as the strata. The three arms of the trial are:

  • Intervention - Provider intervention
  • Intervention - Provider plus school-based malaria activities
  • Control - Expected practice (once RDTs have been introduced)

CAMEROON

Two interventions will be evaluated: (i) the introduction of rapid diagnostic tests (RDTs) with basic provider training on malaria diagnosis and treatment; and (ii) the basic provider training [as under (i)] plus enhanced provider training to improve the quality of care that includes aspects of interactive self awareness, communication modules between health workers and also between health workers and patients. Types of facilities include: public district hospitals, public health centres (including integrated health centres), mission hospitals and mission health centres (including integrated health centres)in Yaoundé and Bamenda Health Districts. A stratified, cluster randomized trial will be used in which health facilities are the cluster and the two study sites are the strata. The three arms of the trial are:

  • Intervention - RDTs with basic provider training;
  • Intervention - RDTs with basic plus enhanced provider training;
  • Control - which represents current practice and neither intervention will be implemented.
Conditions
Malaria
Being tested
RDTs & Provider Training on Malaria Diagnosis and Treatment, Extended provider training (Cameroon only), School based malaria education (Nigeria only)
Keywords
cost effectiveness, provider knowledge, schools
Medical subject headings
Malaria

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • RDTs & Provider Training on Malaria Diagnosis and TreatmentBehavioural

    Also called RDTs supplied: SD Bioline, Training course

    In Cameroon and Nigeria, malaria RDTs will be made available in health facilities and health care providers will receive training and job aids on malaria diagnosis and treatment. The training course covers the following topics: clinical and parasitological diagnosis of malaria, how to use a rapid diagnostic test, algorithm based on malaria test result, recommended treatment for confirmed malaria cases (including dosage and regimen for artemisinin-based combination therapies), advice for treatment of test-negative patients

  • Extended provider training (Cameroon only)Behavioural

    Also called provider training, quality of care

    2-day training course which supplements basic provider training on malaria diagnosis and treatment, which focuses on understanding change in malaria treatment guidelines, professionalism, and communication skills

  • School based malaria education (Nigeria only)Behavioural

    Also called school based intervention, teachers, peer health educators

    Schools will be invited to undertake activities to raise awareness about malaria RDTs and treatment among children and community members. The intervention includes training teachers on peer health education, malaria awareness activities and providing support to hold a malaria educational event

Study groups in NCT01350752
Study groupRoleWhat they receive
ControlNo interventionIn Cameroon: Existing practice (with microscopy widely available) In Nigeria: Expected practice (RDTs will be provided with basic instructions)
Provider InterventionActive comparatorCameroon: Introduce malaria RDTs with basic provider training and job aids on malaria diagnosis and treatment. This involved 1-day training on: 1) Malaria Diagnosis; 2) Rapid Diagnostic Testing; 3) Malaria Treatment. These modules explain that all febrile patients should be tested for malaria; procedures for using an RDT; that confirmed cases of uncomplicated malaria should be treated with an ACT; and test-negative patients should not be given an antimalarial. Nigeria: Introduce malaria RDTs with provider training and job aids on malaria diagnosis and treatment. This involved a 2-day training workshop and support visits. The training covered the following topics: causes and symptoms of malaria; demonstration on how to use an RDT; updated malaria guidelines; and communications skills. The training used a combination of seminars and facilitated small-group work, such as a treatment algorithm game, problem-solving exercises, self-developed participatory drama and role-playing.
Receives: Behavioral: RDTs & Provider Training on Malaria Diagnosis and Treatment
Extended interventionActive comparatorCameroon: Introduce malaria RDTs with basic provider training and job aids on malaria diagnosis and treatment AND enhanced provider training on improving quality of care. Clinicians received 3-days of training: the first day was identical to the basic intervention, while the remainder of the course covered three additional modules targeting improvements in quality of care: 4) Adapting to Change; 5) Professionalism; 6) Communicating Effectively. Nigeria: Introduce malaria RDTs with provider training and job aids on malaria diagnosis and treatment AND School-based malaria education intervention (with drama, peer-health education and distribution of health education materials). In addition, teachers and Peer Health Educators were offered support to hold malaria events in which parents, guardians, and other community members could participate in the same types of activities.
Receives: Behavioral: RDTs & Provider Training on Malaria Diagnosis and Treatment; Behavioral: Extended provider training (Cameroon only); Behavioral: School based malaria education (Nigeria only)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion of febrile patients receiving treatment as recommended in clinical guidelines for uncomplicated malaria

    Recommended treatment is defined as

    • Febrile patients should be tested for malaria, either using microscopy or using a RDT
    • Artemisinin-based Combination Therapy (ACT) should be provided if the patient has a positive malaria test result
    • No antimalarial should be provided if patient has a negative test result.

    Measured: As patients exit the health facility

Secondary outcomes (1)
  1. Health worker knowledge

    Mean score (and standard deviation) in HW knowledge on malaria diagnosis and treatment

    Measured: Two time points: (i) pre and post training evaluation and (ii) during the provider survey (3 months after implementation of interventions)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 May 2011 (estimated)
  2. Study startMay 2011
  3. Primary completionSep 2012
  4. Study completionJan 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
6,513 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01350752
Sponsor's protocol ID
REACT
Acronym
REACT
Status last verified
Oct 2013
First submitted
9 May 2011
Last updated
9 Sep 2016
Results posted
No
Data monitoring committee
No

Publications

  • Onwujekwe O, Mangham-Jefferies L, Cundill B, Alexander N, Langham J, Ibe O, Uzochukwu B, Wiseman V. Effectiveness of Provider and Community Interventions to Improve Treatment of Uncomplicated Malaria in Nigeria: A Cluster Randomized Controlled Trial. PLoS One. 2015 Aug 26;10(8):e0133832. doi: 10.1371/journal.pone.0133832. eCollection 2015.

    PubMed 26309023
  • Mbacham WF, Mangham-Jefferies L, Cundill B, Achonduh OA, Chandler CI, Ambebila JN, Nkwescheu A, Forsah-Achu D, Ndiforchu V, Tchekountouo O, Akindeh-Nji M, Ongolo-Zogo P, Wiseman V. Basic or enhanced clinician training to improve adherence to malaria treatment guidelines: a cluster-randomised trial in two areas of Cameroon. Lancet Glob Health. 2014 Jun;2(6):e346-58. doi: 10.1016/S2214-109X(14)70201-3. Epub 2014 Apr 25.

    PubMed 25103303
  • Achonduh OA, Mbacham WF, Mangham-Jefferies L, Cundill B, Chandler C, Pamen-Ngako J, Lele AK, Ndong IC, Ndive SN, Ambebila JN, Orang-Ojong BB, Metoh TN, Akindeh-Nji M, Wiseman V. Designing and implementing interventions to change clinicians' practice in the management of uncomplicated malaria: lessons from Cameroon. Malar J. 2014 May 29;13:204. doi: 10.1186/1475-2875-13-204.

    PubMed 24885621
  • Wiseman V, Ogochukwu E, Emmanuel N, Lindsay J M, Bonnie C, Jane E, Eloka U, Benjamin U, Obinna O. A cost-effectiveness analysis of provider and community interventions to improve the treatment of uncomplicated malaria in Nigeria: study protocol for a randomized controlled trial. Trials. 2012 Jun 9;13:81. doi: 10.1186/1745-6215-13-81.

    PubMed 22682276

Questions about this trial

What is this clinical trial studying?

A study testing RDTs & Provider Training on Malaria Diagnosis and Treatment, Extended provider training (Cameroon only) and School based malaria education (Nigeria only) in people with Malaria, run by London School of Hygiene and Tropical Medicine at 3 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Cameroon, Nigeria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion of febrile patients receiving treatment as recommended in clinical guidelines for uncomplicated malaria (time frame: As patients exit the health facility). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01350752, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2016; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in